锦盛新材 reported revenue of ¥0.16B for the period ended 2026-06-30, +4.2% year on year. Net income was ¥-0.01B, a -7.7% net margin on a 18.3% gross margin. The largest revenue line is 注塑件 at 97% of the total. Free cash flow for the period was ¥0.02B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.16B | +4.2% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 18.3% | Net margin -7.7% |
| Revenue Q/Q | +19.0% | — |
| Segment | Revenue | Share |
|---|---|---|
| 注塑件 | ¥0.15B | 96.6% |
| 其他(补充) | ¥0.00B | 1.9% |
| 贸易类 | ¥0.00B | 1.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 81.7% |
| R&D | ¥0.01B | 4.1% |
| SG&A | ¥0.03B | 19.0% |
| Tax & other | ¥-0.00B | -0.1% |
| Item | Amount |
|---|---|
| Total assets | ¥0.72B |
| Total liabilities | ¥0.19B |
| Shareholders' equity | ¥0.53B |
| Equity / assets | 73.5% |
| Operating cash flow | ¥0.02B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥0.02B |
| Cash conversion (OCF / net income) | 451% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新强联 ・ 交大思诺 ・ 四会富仕 ・ 申昊科技 ・ 中兰环保 ・ 图南股份 ・ 科思股份 ・ 协创数据 ・ 科拓生物 ・ 西域旅游 ・ 锋尚文化 ・ 美畅股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies